US › Healthcare

GeoVax Labs Inc (GOVX)

US · Healthcare · Biotechnology

$0.76+5.15%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-4.4M

Profit YoY

+17.6%

EPS

$-0.97

EPS estimate

$-2.16

EPS came in at -0.97 against a street estimate of -2.16 — a beat of 55.1%.

Key statistics

Market cap

$3.5M

Forward P/E

9.7

P/B

2.05

Book value

$0.24

EPS (TTM)

$-5.62

52-week high

$20.00

52-week low

$0.64

50-day MA

$1.42

200-day MA

$4.19

Beta

3.67

Analyst view

Analysts rate GeoVax Labs Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $10.00.

Shareholding

Insiders

3.20%

Institutions

8.64%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	9.31%
Geode Capital Management, LLC	1.25%
Virtu Financial LLC	0.36%
Vanguard Fiduciary Trust Co	0.18%
UBS Group AG	0.15%
Tower Research Capital LLC	0.12%
Vanguard Capital Management, LLC	0.11%
BlackRock Inc	0.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for GeoVax Labs Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.